CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Mechanical circulatory support devices for acute right ventricular failure Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure The year in cardiology: heart failure: The year in cardiology 2019 Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America Mechanical circulatory support devices in advanced heart failure: 2020 and beyond Association Between Functional Impairment and Medication Burden in Adults with Heart Failure Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Review ArticleVolume 7, Issue 3, March 2019

JOURNAL:JACC: Heart Failure Article Link

Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?

P Z Maslov, JK Kim, E Argulian et al. Keywords: diastolic function; estrogen; HFpEF; post-menopausal

ABSTRACT


Post-menopausal women exhibit an exponential increase in the incidence of heart failure with preserved ejection fraction compared with men of the same age, which indicates a potential role of hormonal changes in subclinical and clinical diastolic dysfunction. This paper reviews the preclinical evidence that demonstrates the involvement of estrogen in many regulatory molecular pathways of cardiac diastolic function and the clinical data that investigates the effect of estrogen on diastolic function in post-menopausal women. Published reports show that estrogen deficiency influences both early diastolic relaxation via calcium homeostasis and the late diastolic compliance associated with cardiac hypertrophy and fibrosis. Because of the high risk of diastolic dysfunction and heart failure with preserved ejection fraction in post-menopausal women and the positive effects of estrogen on preserving cardiac function, further clinical studies are needed to clarify the role of endogenous estrogen or hormone replacement in mitigating the onset and progression of heart failure with preserved ejection fraction in women.